In particular, regarding cell interactions in the TIME, researchers have found that nearly 20% of TNBC patients have PD‐L1+ cells on the tumor cell surface and that PD‐L1‐positive tumors have a higher CD8+ cell density than PD‐L1‐negative tumors in TNBC specimens.7 The gene discussed is CD8A; the disease is neoplasm.